Elderly Patients (Age 70 Years or Older) With Secondary Acute Myeloid Leukemia or Acute Myeloid Leukemia Developed Concurrently to Another Malignant Disease
Elodie Collinge(Hospices Civils de Lyon), Xavier Thomas(Hôpital Lyon Sud), Mohamed Elhamri(Hôpital Edouard Herriot), Sandrine Loron(Hôpital de la Croix-Rousse), Fiorenza Barraco(Hôpital Lyon Sud), Étienne Paubelle(Centre Hospitalier Universitaire Amiens-Picardie), Marie‐Virginie Larcher, Alexandre Deloire(Lyon 1 Université), Gilles Salles(Memorial Sloan Kettering Cancer Center), Eric Wattel(Université Claude Bernard Lyon 1), Sophie Ducastelle(Hôpital Lyon Sud), Hélène Labussière(Hôpital Lyon Sud), Maël Heiblig(Université Claude Bernard Lyon 1)
Cited by 10
Related Papers
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
|New England Journal of Medicine|2014|1.1k
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
|The Lancet|2012|1k
Should Adolescents With Acute Lymphoblastic Leukemia Be Treated as Old Children or Young Adults? Comparison of the French FRALLE-93 and LALA-94 Trials
|Journal of Clinical Oncology|2003|606
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience
|Advances in Therapy|2017|603